Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors - Juhan-Vague, I; Renucci, JF; Grimaux, M; Morange, PE; Gouvernet, J; Gourmelin, Y; Alessi, MC (Arterioscler Thromb Vasc Biol, 2000)